A Phase I, Open-Label, Single-Dose Trial To Determine The Safety And Pharmacokinetics Of Minocin (Minocycline) For Injection In Subjects With Renal Insufficiency
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Minocycline (Primary)
- Indications Renal failure
- Focus Adverse reactions
- Sponsors Melinta Therapeutics
- 03 Jul 2018 Status changed from recruiting to discontinued.
- 05 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 05 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.